Aptus Pharma Performance
- Today's Low
- ₹245
- Today's High
- ₹260
- 52 Week Low
- ₹32
- 52 Week High
- ₹260
- Open Price₹253
- Previous Close₹248
- Volume25,600
- 50 DMA₹212.60
- 100 DMA₹178.80
- 200 DMA-
Aptus Pharma Chart
Investment Returns
- Over 1 Month + 13.46%
- Over 3 Month + 68.01%
- Over 6 Month + 180.33%
Smart Investing Starts Here Start SIP with Aptus Pharma for Steady Growth!
Aptus Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 92.8
- PEG Ratio
- -
- Market Cap Cr
- 429
- P/B Ratio
- 18.4
- Average True Range
- 9.6
- EPS
- 2.7
- Dividend Yield
- 0
- MACD Signal
- 9.5
- RSI
- 66.09
- MFI
- 77.17
Latest Stock News Updates
Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- BSE India
- 3 days 6 hours ago
Intimation Regarding Credit Rating assigned by CARE Ratings under Reluation 30 of SEBI (LODR) Regulations, 2015.
- BSE India
- 3 weeks 3 days ago
Outcome of Board Meeting held on 12th June, 2026
- BSE India
- 1 month 1 week ago
Aptus Pharma Financials
Aptus Pharma Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 14
- 20 Day
- ₹234.00
- 50 Day
- ₹212.60
- 100 Day
- ₹178.80
- 200 Day
- -
Resistance and Support
- R3 274.00
- R2 267.00
- R1 259.10
- S1 244.20
- S2 237.20
- S3 229.30
Aptus Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-06-12 | Preferential Issue of shares & Others | Inter-alia, to consider 1. Evaluate and deliberate upon the proposal for raising of funds. 2. If thought fit, to authorize the Managing Director of the Company. 3. Other business matters. |
| 2026-04-27 | Audited Results | |
| 2026-03-24 | Bonus issue & Others | Inter-alia, to consider 1. Increase in Authorized Share Capital subject to approval of members of the Company. 2. Other business matters. |
| 2025-11-10 | Half Yearly Results |
About Aptus Pharma
Aptus Pharma is engaged in the business of marketing, and distribution of finished pharmaceutical formulations. View More- NSE Symbol
- APPL
- BSE Symbol
- 544529
- ISIN
- INE15XJ01010
Similar Stocks to Aptus Pharma
Popular Stocks
Aptus Pharma FAQs
Aptus Pharma share price is ₹250 As on 21 July, 2026 | 19:11
The Market Cap of Aptus Pharma is ₹428.8 Cr As on 21 July, 2026 | 19:11
The P/E ratio of Aptus Pharma is 92.8 As on 21 July, 2026 | 19:11
The PB ratio of Aptus Pharma is 18.4 As on 21 July, 2026 | 19:11
The 52 week High & Low of Aptus Pharma is ₹260/₹32.3 respectively As on 21 July, 2026 | 19:11
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.